About Saros Therapeutics

Saros Therapeutics is working to enhance patients' response to immunotherapy by harnessing the STING pathway with a strategy to overcome the limitations of prior STING agonists. In combination with existing immunotherapies, this approach has the potential to enable a safe and more effective immune response against the tumor than with immunotherapy alone.

Company Highlights
Year Founded

2021

icon-altEmployees

9

Location (HQ)

USA

Since Last Funding

11 months

Monthly Website Visitors

3.8K

icon-altTotal Investment Amt

$2M

Last Funding Round

Grant

icon-altMoM Headcount Growth

12.35%

icon-altYoY Headcount Growth

49.18%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Life Science

Biotechnology Research